First, the patient sample size was small and the target population for the CKD Stages 1–5 study was much smaller than the CKD Stage 5D population, consequently the FD prevalence may not be significant.
← all excerpts
Screening of Fabry disease in patients with chronic kidney disease in Japan.
1
—
—